Molecular Devices, LLC, BioTek Instruments, Inc. and Tecan Trading AG are Dominating the Global Microplate Reader Market in 2018

Microplate Reader Market is growing at a substantial CAGR of 5.4% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below:

Access Full Report at https://www.databridgemarketresearch.com/reports/global-microplate-reader-market

Global microplate reader market is a highly concentrated market which includes key players and local players. The market has witnessed increased various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to increasing demand of microplate readers and growing number of diseases.

The market has witnessed developments in terms of merger and acquisitions, partnerships or product launches to enhance the product portfolio to meet the rising demand of innovative monitoring technology in microplate reader market. For instance, In June 2018, Molecular Devices, LLC introduced ABS Plus and SpectraMax ABS Absorbance Microplate Readers that helps in protein quantitation and Microbial health. The launch was successful in maintaining the flexibility of monochromatic based systems and for selecting the wavelength for every assay as to meet the needs of the researchers globally. This will enhance the product portfolio of the company in the market.

Molecular Devices, LLC is dominating the global microplate reader market in 2018. The other key players in the market include BioTek Instruments, Inc., Tecan Trading AG, Bio-Rad Laboratories, Inc., PerkinElmer Inc, Promega Corporation, Awareness Technology, Inc, Biochrom, BMG LABTECH GmbH, BERTHOLD TECHNOLOGIES GmbH & Co. KG, Dynex Technologies, High Technology, Inc, Hercuvan Lab Systems, Hudson Robotics, Lonza, Rayto Life and Analytical Sciences Co.,Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Thermo Fisher Scientific Inc. among others.

Molecular Devices, LLC

Molecular devices, LLC is a private company which is headquartered in California, U.S. The company focuses on providing innovative and analytical solutions for the research and pharmaceutical development. The company has wide range of product categories such as microplate readers, cellular imaging systems, biologics by fortebio, axon - patch clamp, flipr penta high-throughput cellular screening in which microplate readers is the market focused category. The company has more than 1100 employees.

  • In July 2016, Molecular Devices, LLC Multi- Mode SpectraMax M5e launched to the International Space Station which helped in providing the researchers the opportunity to conduct microplate readers experiment in microgravity to operate efficiently in space station and to maintain the ease-of–use which is required by NanoRacks to maintain flexibility in the laboratories. This will enhance the product portfolio of the company in the market.

The company has its presence in America, Europe, Asia, Africa and Oceania. The company has various subsidiaries such as ForteBio (U.S.), Molecular Devices (U.K.) Limited (U.K.), Molecular Devices (Germany) GmbH (Germany), Applied Imaging (U.S.), Applied Imaging (Israel) Ltd. (Israel) among others.

BioTek Instruments, Inc.

BioTek Instruments, Inc. is a private company which is headquartered in Vermont, U.S and was founded in 1968. The company focuses on the excellent performance across diverse applications which can result in a cost effective system to keep their research move forward in an innovative way. The company has wide range of product category such as imaging and microscopy, detection, liquid handling, software, robotics, technologies in which detection is the market focused category.

  • In January 2019, BioTek Instruments, Inc launched New Epoch 2 Microplate Spectrophotometer which was launched for the performance of absorbance measurements i.e. scanning the wavelength up to 200-999 nm to accommodate nucleic acid, ELISA, Endotoxin, microbial growth etc. The launch was helpful in promoting cost efficiency, high performance, interaction of biomolecular cellular structure across various applications.

The company has its presence in Asia-Pacific, Europe, Middle East and Africa, North America, South America.

Tecan Trading AG

Tecan Trading AG is a public company which is headquartered in Zürich, Switzerland and was founded in 1980. The company is engaged in developing, manufacturing and marketing of automated laboratory solutions and instruments to have innovative and advanced technology for the customers. The company has multiple business segments such as life science business and partnering business in which life science business is the market focused segment. The company has wide range of product portfolio such as life sciences; diagnostics, partnering in which life sciences is the market focused category. The company has approx. 1,598 employees as of 31st December, 2018.

  • In November 2015, Tecan Trading AG completed acquisition of SIAS to expand their business. The acquisition was helpful in the supply of modular, innovative modular solutions for the laboratory to adapt to the technological advancements of the products.

The company has its global presence in North America, Europe, Asia-Pacific, South America and Middle East & Africa. The company has various subsidiaries such as NuGEN Technologies (U.S.), Sias AG (Switzerland), Tecan Switzerland Ltd. (Switzerland), SPEware Corporation, Tecan U.S. Inc. (U.S.), Tecan Systems (Switzerland) among others.